In the quest to outshine the broader market, stock pickers diligently seek out stocks with the potential for superior performance. Making the right choices can significantly elevate your wealth.
In the latest session, AMGEN Inc (NASDAQ: AMGN) closed at $315.04 down -0.22% from its previous closing price of $315.75. In other words, the price has decreased by -$0.22 from its previous closing price. On the day, 2.05 million shares were traded. AMGN stock price reached its highest trading level at $315.48 during the session, while it also had its lowest trading level at $312.24.
Ratios:
For a deeper understanding of AMGEN Inc’s stock, let’s take a closer look at its various ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 14.14 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 16.28. For the most recent quarter (mrq), Quick Ratio is recorded 0.95 and its Current Ratio is at 1.26. In the meantime, Its Debt-to-Equity ratio is 10.36 whereas as Long-Term Debt/Eq ratio is at 9.74.
On November 14, 2024, Citigroup started tracking the stock assigning a Neutral rating and target price of $335.Citigroup initiated its Neutral rating on November 14, 2024, with a $335 target price.
Insider Transactions:
Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on Feb 19 ’25 when Santos Esteban sold 8,711 shares for $292.84 per share. The transaction valued at 2,550,903 led to the insider holds 71,546 shares of the business.
REESE DAVID M sold 25,225 shares of AMGN for $7,679,524 on Feb 21 ’25. The EVP & Chief Technology Officer now owns 36,922 shares after completing the transaction at $304.44 per share. On Feb 19 ’25, another insider, REESE DAVID M, who serves as the EVP & Chief Technology Officer of the company, sold 8,711 shares for $293.22 each. As a result, the insider received 2,554,224 and left with 62,147 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, AMGN now has a Market Capitalization of 169241067520 and an Enterprise Value of 218147045376. As of this moment, AMGEN’s Price-to-Earnings (P/E) ratio for their current fiscal year is 41.75, and their Forward P/E ratio for the next fiscal year is 14.56. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 10.57. For the stock, the TTM Price-to-Sale (P/S) ratio is 5.09 while its Price-to-Book (P/B) ratio in mrq is 28.78. Its current Enterprise Value per Revenue stands at 6.527 whereas that against EBITDA is 14.392.
Stock Price History:
The Beta on a monthly basis for AMGN is 0.58, which has changed by 0.1407466 over the last 52 weeks, in comparison to a change of 0.08190584 over the same period for the S&P500. Over the past 52 weeks, AMGN has reached a high of $346.85, while it has fallen to a 52-week low of $253.30. The 50-Day Moving Average of the stock is 6.64%, while the 200-Day Moving Average is calculated to be 2.76%.
Shares Statistics:
For the past three months, AMGN has traded an average of 3.21M shares per day and 2751360 over the past ten days. A total of 536.90M shares are outstanding, with a floating share count of 536.14M. Insiders hold about 0.20% of the company’s shares, while institutions hold 79.18% stake in the company. Shares short for AMGN as of 1740700800 were 16158990 with a Short Ratio of 5.04, compared to 1738281600 on 12741466. Therefore, it implies a Short% of Shares Outstanding of 16158990 and a Short% of Float of 3.01.
Dividends & Splits
According to the company, the forward annual dividend rate for AMGN is 9.13, from 9.0 in the trailing year. Against a Trailing Annual Dividend Yield of 0.028503563The stock’s 5-year Average Dividend Yield is 2.99. The current Payout Ratio is 119.05% for AMGN, which recently paid a dividend on 2025-02-14 with an ex-dividend date of 1747353600. Stock splits for the company last occurred on 1999-11-22 when the company split stock in a 2:1 ratio.
Earnings Estimates
At present, 21.0 analysts are actively evaluating the performance of AMGEN Inc (AMGN) in the stock market.The consensus estimate for the next quarter is $5.34, with high estimates of $5.67 and low estimates of $4.97.
Analysts are recommending an EPS of between $21.21 and $20.06 for the fiscal current year, implying an average EPS of $20.64. EPS for the following year is $21.52, with 26.0 analysts recommending between $23.53 and $19.43.
Revenue Estimates
A total of 19 analysts believe the company’s revenue will be $8.05B this quarter.It ranges from a high estimate of $8.46B to a low estimate of $7.71B. As of the current estimate, AMGEN Inc’s year-ago sales were $7.45BFor the next quarter, 19 analysts are estimating revenue of $8.87B. There is a high estimate of $9.16B for the next quarter, whereas the lowest estimate is $8.66B.
A total of 28 analysts have provided revenue estimates for AMGN’s current fiscal year. The highest revenue estimate was $35.92B, while the lowest revenue estimate was $33.79B, resulting in an average revenue estimate of $35.09B. In the same quarter a year ago, actual revenue was $33.42BBased on 27 analysts’ estimates, the company’s revenue will be $35.83B in the next fiscal year. The high estimate is $38.64B and the low estimate is $34.48B.
